Tumor Biology

, Volume 36, Issue 1, pp 121–127 | Cite as

Polymorphisms in IL-4/IL-13 pathway genes and glioma risk: an updated meta-analysis

Review

Abstract

Polymorphisms in interleukin (IL)-4/IL-13 pathway genes have previously been reported to be associated with glioma susceptibility, although results are inconsistent. We therefore performed an updated meta-analysis to determine a more precise estimation of this relationship. Twelve eligible studies were identified by searching PubMed, EMBASE, Web of Science, and the Cochrane Library electronic databases. Nine polymorphisms in genes within the IL-4/IL-13 pathway (IL-4 rs2243250, rs2070874, rs2243248, IL-4R rs1805011, rs1805012, rs1805015, rs1801275, and IL-13 rs20541 and rs1800925) were assessed for their relationship with glioma risk by computing odds ratios (ORs) and corresponding 95 % confidence intervals (CIs). Akaike’s information criterion (AIC) was used to identify the best genetic model for each polymorphism. No association between IL-4/IL-13 pathway genetic polymorphisms and glioma risk was observed in the overall population, although a significant association was found between rs2234248 and glioblastoma when stratified by histological subtype (log-additive model, OR 1.57, 95 % CI 1.11–2.24). This meta-analysis therefore suggested that IL-4/IL-13 pathway genetic polymorphisms are not associated with glioma risk.

Keywords

Glioma Meta-analysis Interleukin-4 Interleukin-4R Interleukin-13 Single nucleotide polymorphism 

Notes

Acknowledgments

We thank Dr. Melissa L. Bondy from the Texas MD Anderson Cancer Center and Dr. Kyle M. Walsh from the Helen Diller Family Comprehensive Cancer Center for generously providing their data.

Conflicts of interest

None

Supplementary material

13277_2014_2895_MOESM1_ESM.doc (39 kb)
Online Resource 1 Scale for methodological quality assessment (DOC 39 kb)
13277_2014_2895_Fig4_ESM.gif (123 kb)
Online Resource 2

Meta-analysis for the association between IL-4/IL-13 pathway genetic polymorphisms and glioblastoma risk (GIF 122 kb)

13277_2014_2895_MOESM2_ESM.eps (1.5 mb)
High resolution image (EPS 1527 kb)

References

  1. 1.
    Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109(1):93–108. doi: 10.1007/s00401-005-0991-y.CrossRefPubMedGoogle Scholar
  2. 2.
    Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006;2(9):494–503. doi: 10.1038/ncpneuro0289. quiz 1 p following 16.CrossRefPubMedGoogle Scholar
  3. 3.
    Schoemaker MJ, Swerdlow AJ, Hepworth SJ, McKinney PA, van Tongeren M, Muir KR. History of allergies and risk of glioma in adults. Int J Cancer. 2006;119(9):2165–72. doi: 10.1002/ijc.22091.CrossRefPubMedGoogle Scholar
  4. 4.
    Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC, et al. Allergic conditions and brain tumor risk. Am J Epidemiol. 2007;166(8):941–50. doi: 10.1093/aje/kwm203.CrossRefPubMedGoogle Scholar
  5. 5.
    Linos E, Raine T, Alonso A, Michaud D. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst. 2007;99(20):1544–50. doi: 10.1093/jnci/djm170.CrossRefPubMedGoogle Scholar
  6. 6.
    Chen C, Xu T, Chen J, Zhou J, Yan Y, Lu Y, et al. Allergy and risk of glioma: a meta-analysis. Eur J Neurol. 2011;18(3):387–95. doi: 10.1111/j.1468-1331.2010.03187.x.CrossRefPubMedGoogle Scholar
  7. 7.
    Calboli FC, Cox DG, Buring JE, Gaziano JM, Ma J, Stampfer M, et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst. 2011;103(21):1588–95. doi: 10.1093/jnci/djr361.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Schlehofer B, Siegmund B, Linseisen J, Schuz J, Rohrmann S, Becker S, et al. Primary brain tumours and specific serum immunoglobulin E: a case–control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy. 2011;66(11):1434–41. doi: 10.1111/j.1398-9995.2011.02670.x.CrossRefPubMedGoogle Scholar
  9. 9.
    Akdis M. Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol. 2006;18(6):738–44. doi: 10.1016/j.coi.2006.06.003.CrossRefPubMedGoogle Scholar
  10. 10.
    de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol. 1998;102(2):165–9. doi: 10.1016/S0091-6749(98)70080-6.CrossRefPubMedGoogle Scholar
  11. 11.
    Barna BP, Estes ML, Pettay J, Iwasaki K, Zhou P, Barnett GH. Human astrocyte growth regulation: interleukin-4 sensitivity and receptor expression. J Neuroimmunol. 1995;60(1–2):75–81. doi: 10.1016/0165-5728(95)00055-7.CrossRefPubMedGoogle Scholar
  12. 12.
    Liu H, Jacobs BS, Liu J, Prayson RA, Estes ML, Barnett GH, et al. Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma. Cancer Immunol Immunother. 2000;49(6):319–24. doi: 10.1007/s002620000110.CrossRefPubMedGoogle Scholar
  13. 13.
    Loza MJ, Chang BL. Association between Q551R IL4R genetic variants and atopic asthma risk demonstrated by meta-analysis. J Allergy Clin Immunol. 2007;120(3):578–85. doi: 10.1016/j.jaci.2007.05.019.CrossRefPubMedGoogle Scholar
  14. 14.
    Cui L, Jia J, Ma CF, Li SY, Wang YP, Guo XM, et al. IL-13 polymorphisms contribute to the risk of asthma: a meta-analysis. Clin Biochem. 2012;45(4–5):285–8. doi: 10.1016/j.clinbiochem.2011.12.012.CrossRefPubMedGoogle Scholar
  15. 15.
    Schwartzbaum J, Ahlbom A, Malmer B, Lonn S, Brookes AJ, Doss H, et al. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res. 2005;65(14):6459–65. doi: 10.1158/0008-5472.CAN-04-3728.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Wiemels JL, Wiencke JK, Kelsey KT, Moghadassi M, Rice T, Urayama KY, et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1229–35. doi: 10.1158/1055-9965.EPI-07-0041.CrossRefPubMedGoogle Scholar
  17. 17.
    Schwartzbaum JA, Ahlbom A, Lonn S, Malmer B, Wigertz A, Auvinen A, et al. An international case–control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2448–54. doi: 10.1158/1055-9965.EPI-07-0480.CrossRefPubMedGoogle Scholar
  18. 18.
    Guo J, Shi L, Li M, Xu J, Yan S, Zhang C, et al. Association of the interleukin-4Ralpha rs1801275 and rs1805015 polymorphisms with glioma risk. Tumour Biol. 2013. doi: 10.1007/s13277-013-1080-9.PubMedCentralGoogle Scholar
  19. 19.
    Sun G, Wang X, Shi L, Yue X, Fu L, Chen C, et al. Association between polymorphisms in interleukin-4Ralpha and interleukin-13 and glioma risk: a meta-analysis. Cancer Epidemiol. 2013;37(3):306–10. doi: 10.1016/j.canep.2013.01.003.CrossRefPubMedGoogle Scholar
  20. 20.
    Brenner AV, Butler MA, Wang SS, Ruder AM, Rothman N, Schulte PA, et al. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis. 2007;28(12):2543–7. doi: 10.1093/carcin/bgm210.CrossRefPubMedGoogle Scholar
  21. 21.
    Amirian E, Liu Y, Scheurer ME, El-Zein R, Gilbert MR, Bondy ML. Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol. 2010;12(5):444–52. doi: 10.1093/neuonc/nop057.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Walsh KM, Anderson E, Hansen HM, Decker PA, Kosel ML, Kollmeyer T, et al. Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies. Genet Epidemiol. 2013;37(2):222–8. doi: 10.1002/gepi.21707.CrossRefPubMedGoogle Scholar
  23. 23.
    Backes DM, Siddiq A, Cox DG, Calboli FC, Gaziano JM, Ma J, et al. Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma. J Neurooncol. 2013;113(2):229–38. doi: 10.1007/s11060-013-1122-6.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Al-Moundhri MS, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, Ganguly SS, et al. Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population. Gastric Cancer. 2006;9(4):284–90. doi: 10.1007/s10120-006-0392-5.CrossRefPubMedGoogle Scholar
  25. 25.
    Gao LB, Pan XM, Li LJ, Liang WB, Zhu Y, Zhang LS, et al. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat. 2011;125(3):827–35. doi: 10.1007/s10549-010-0995-8.CrossRefPubMedGoogle Scholar
  26. 26.
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. doi: 10.1002/sim.1186.CrossRefPubMedGoogle Scholar
  27. 27.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88. doi: 10.1016/0197-2456(86)90046-2.CrossRefPubMedGoogle Scholar
  28. 28.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48. doi: 10.1093/jnci/22.4.719.PubMedGoogle Scholar
  29. 29.
    Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676–80. doi: 10.1001/jama.295.6.676.CrossRefPubMedGoogle Scholar
  30. 30.
    Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41(8):905–8. doi: 10.1038/ng.408.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Sanson M, Hosking FJ, Shete S, Zelenika D, Dobbins SE, Ma Y, et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet. 2011;20(14):2897–904. doi: 10.1093/hmg/ddr192.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM, et al. Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat Genet. 2014;46(7):731–5. doi: 10.1038/ng.3004.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899–904. doi: 10.1038/ng.407.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Li W, Qian X, Teng H, Ding Y, Zhang L. Association of interleukin-4 genetic polymorphisms with sporadic Alzheimer’s disease in Chinese Han population. Neurosci Lett. 2014;563:17–21. doi: 10.1016/j.neulet.2014.01.019.CrossRefPubMedGoogle Scholar
  35. 35.
    Cinek O, Vavrincova P, Striz I, Drevinek P, Sedlakova P, Vavrinec J, et al. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J Rheumatol. 2004;31(6):1206–10.PubMedGoogle Scholar
  36. 36.
    Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Lonn S, Soderberg KC, et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer. 2003;106(3):423–8. doi: 10.1002/ijc.11230.CrossRefPubMedGoogle Scholar
  37. 37.
    Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer. 1999;82(2):155–60. doi: 10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P.CrossRefPubMedGoogle Scholar
  38. 38.
    Maier LM, Howson JM, Walker N, Spickett GP, Jones RW, Ring SM, et al. Association of IL13 with total IgE: evidence against an inverse association of atopy and diabetes. J Allergy Clin Immunol. 2006;117(6):1306–13. doi: 10.1016/j.jaci.2005.12.1354.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Peiqin Chen
    • 1
  • Chao Chen
    • 2
  • Kun Chen
    • 1
  • Tao Xu
    • 1
  • Chun Luo
    • 1
  1. 1.Department of Neurosurgery, Changzheng HospitalSecond Military Medical UniversityShanghaiChina
  2. 2.Department of Neurosurgery, Changhai HospitalSecond Military Medical UniversityShanghaiChina

Personalised recommendations